SEC Form 4 · accession 0001131096-18-000065
ATHENAHEALTH INC · ATHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradford Kyle Armbrester
Officer — SVP, Chief Product Officer
Period of report
Feb 26, 2018
Accepted (ET)
Feb 28, 2018 · 7:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131096
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 26, 2018 | S | 1,795 | $140.66 | D | 9,525 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.6562 to $140.6554, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote (1).
- F2Includes 9,525 units of common stock granted pursuant to restricted stock unit ("RSU") awards under the athenahealth, Inc. 2007 Stock Option and Incentive Plan, as amended and restated. The RSUs are subject to time-based vesting and will be settled only in stock.